Nu Aire Deal Fuels Kewaunee Sales, Margins and Cash Flow; Debt, PIK and Working Capital Climb

Kewaunee Scientific Corporation (NASDAQ: KEQU) - Quick read on what's happening inside the company

All dollar amounts are presented in the company 10‑Q and are shown as reported (amounts are in thousands unless noted).

What's happening inside

* The company closed the Nu Aire acquisition (Nov 1, 2024) and is integrating operations - Nu Aire added $19,700 of revenue and $696 of net earnings in the quarter.

* Revenue and margins expanded materially quarter‑over‑quarter driven by Nu Aire contribution and improved manufacturing productivity.

* Balance sheet shows stronger cash generation and a healthy backlog, but leverage increased via acquisition funding (term loan, seller notes) and a large sale‑leaseback financing liability.

Positive income‑statement items

* Net sales: $71,104 vs $48,393 (prior year quarter) - strong top‑line growth.

* Gross profit: $20,930 vs $12,488; gross margin: 29.4% vs 25.8% - margin expansion vs prior year.

* Operating profit: $4,810 vs $2,575 - operating leverage despite acquisition-related cost increases.

* Net earnings attributable to Kewaunee: $3,093 vs $2,193; diluted EPS: $1.04 vs $0.74.

* Operating cash flow turned positive: Net cash provided by operating activities $5,791 vs $(794) prior year.

* Backlog remains large: $205.0 million (July 31, 2025) vs $159.4 million (July 31, 2024).

Negative income‑statement / financial pressure items

* Operating expenses rose to $16,120 (22.7% of sales) from $9,913 (20.5%) - acquisition and SG&A increases lifted expense base.

* Interest expense jumped to $1,058 vs $472 - higher debt and financing costs (includes PNC term loan, seller notes, financing liability).

* Income tax expense increased to $761 (effective rate 19.4%) vs $192 (7.9%) - foreign tax mix and discrete items altered rate.

* Seller notes accrue PIK interest ($445 recorded in quarter) - adds non‑cash interest and future cash obligations; Seller Notes balance $24,380.

* Receivables remain high: $56,897 (down from $62,384 at Apr 30, 2025) - working capital tied up in receivables; inventories increased to $34,923.

Key statistics & balance sheet / liquidity

* Cash and cash equivalents: $19,489; Cash + restricted cash: $20,441 (end of period).

* Working capital: $66,662; Current ratio: 2.3:1 (July 31, 2025).

* Total assets: $193,486; Total liabilities: $124,617; Total equity: $68,869.

* Long‑term debt (ex leases): $37,380 (PNC Loan $13,000; Seller Notes $24,380).

* Financing liability (sale‑leaseback): carrying value $27,227 (imputed remaining payments total $39,514).

* Weighted average shares - diluted: 2,963; basic: 2,851. Outstanding shares as of Sept 9, 2025: 2,865,694.

* Stock repurchase program: 100,603 shares available; no repurchases in the quarter.

Operational / strategic notes

* Nu Aire acquisition: purchase consideration $52,980; intangible assets $18,600; goodwill ~ $12,487 (final allocation completed).

* Segment mix this quarter: Domestic $54,352; International $16,752. Domestic growth largely driven by Nu Aire.

* Company in compliance with PNC loan covenants at quarter end.

Bottom line (straightforward)

* Kewaunee is growing revenue and margins after the Nu Aire acquisition and generated healthy operating cash flow this quarter. That said, acquisition funding increased interest and non‑cash PIK charges, operating expenses rose, and receivables/inventory remain elevated - all of which keep leverage and working‑capital risk higher than before the deal.

If you want, I can run simple ratios (EBITDA margin, leverage ratios, free‑cash‑flow estimate) or prepare a short SWOT based on this quarter.